ltrasonographic characterization of small nodules in cirrhotic patients using contrast media through splancnic infusion - ND

Phase 1

• Conditions: hepatic cirrhosis; MedDRA version: 9.1Level: LLTClassification code 10019641Term: Hepatic cirrhosis

• Registration Number: EUCTR2007-005364-27-IT
• Lead Sponsor: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-11-23
• Last Update Posted: 8 August 2022

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Age> 18 years
Hepatic cirrhosis
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Cardiopaty

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Secondary Objective: Not declared;Main Objective: Primary endpoint of this study is the identification of contrast enhanced ultrasound criteria to predict the malignant evolution of hepatic lesions in cirrhotic patients, when lesions have not malignant characteristics at basal ultrasound examination and conventional contrasted enhanced techniques (CT and/or MRI).;Primary end point(s): Primary endpoint of this study is the identification of contrast enhanced ultrasound criteria to predict the malignant evolution of hepatic lesions in cirrhotic patients, when lesions have not malignant characteristics at basal ultrasound examination and conventional contrasted enhanced techniques (CT and/or MRI).